Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT ; volume:14 ; number:1 ; year:2021 ; pages:13-16 ; extent:4
Case reports in oncology ; 14, Heft 1 (2021), 13-16 (gesamt 4)

Creator
Kitajima, Kazuhiro
Yamamoto, Shingo
Fujiwara, Masayuki
Suzuki, Hitomi
Yoshimura, Nahomi
Kunimoto, Ryo
Yokoyama, Hiroyuki
Komoto, Hisashi
Yamada, Yusuke
Nagasawa, Seiji
Kanematsu, Akihiro
Oh, Ryoong-Jin
Yamakado, Koichiro

DOI
10.1159/000512068
URN
urn:nbn:de:101:1-2021051300522930016428
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kitajima, Kazuhiro
  • Yamamoto, Shingo
  • Fujiwara, Masayuki
  • Suzuki, Hitomi
  • Yoshimura, Nahomi
  • Kunimoto, Ryo
  • Yokoyama, Hiroyuki
  • Komoto, Hisashi
  • Yamada, Yusuke
  • Nagasawa, Seiji
  • Kanematsu, Akihiro
  • Oh, Ryoong-Jin
  • Yamakado, Koichiro

Other Objects (12)

Disseminated Carcinomatosis of the Bone Marrow from Castration-Resistant Prostate Cancer Revealed by Choline Positron Emission Tomography-Computed Tomography

Disseminated Carcinomatosis of the Bone Marrow from Castration-Resistant Prostate Cancer Revealed by Choline Positron Emission Tomography-Computed Tomography

Targeting molecular resistance in castration-resistant prostate cancer

Targeting molecular resistance in castration-resistant prostate cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Osteoclasts directly influence castration-resistant prostate cancer cells

Osteoclasts directly influence castration-resistant prostate cancer cells

Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer

Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer

Effect of simvastatin on castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Ureter metastatic castration-resistant prostate cancer: a case report

Ureter metastatic castration-resistant prostate cancer: a case report

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Ailanthone: a new potential drug for castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Related objects